La maladie de Parkinson en France (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Receptors, Dopamine D2 (metabolism) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Receptors, Dopamine D2 (genetics) < Receptors, Dopamine D2 (metabolism) < Receptors, Dopamine D2 (physiology)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000090 (2000) I. Aubert [France] ; I. Ghorayeb ; E. Normand ; B. BlochPhenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum.
000098 (2000) P. Damier [France] ; L. Tremblay ; J. Féger ; E C Hirsch[Development of dyskinesias induced by treatment for Parkinson's disease: potential role of first exposure to L-DOPA (or phenomenon of priming)].
000330 (2003) Erwan Bézard [France] ; Sandrine Ferry ; Ulrich Mach ; Holger Stark ; Ludovic Leriche ; Thomas Boraud ; Christian Gross ; Pierre SokoloffAttenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function.
000435 (2004) Igor Sibon [France] ; François TisonVascular parkinsonism.
000A70 (2010) Jacques Darcourt [France] ; Jan Booij ; Klaus Tatsch ; Andrea Varrone ; Thierry Vander Borght ; Ozlem L. Kapucu ; Kjell N Gren ; Flavio Nobili ; Zuzana Walker ; Koen Van LaereEANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2.
000E57 (2012) Jean-Antoine Girault [France]Integrating neurotransmission in striatal medium spiny neurons.
000F75 (2013) Michel Engeln [France] ; Serge H. Ahmed [France] ; Caroline Vouillac [France] ; François Tison [France] ; Erwan Bezard [France] ; Pierre-Olivier Fernagut [France]Reinforcing properties of Pramipexole in normal and parkinsonian rats.
001430 (2014) Annalisa Fico [France] ; Antoine De Chevigny [France] ; Christophe Melon [France] ; Manon Bohic [France] ; Lydia Kerkerian-Le Goff [France] ; Flavio Maina [France] ; Rosanna Dono [France] ; Harold Cremer [France]Reducing glypican-4 in ES cells improves recovery in a rat model of Parkinson's disease by increasing the production of dopaminergic neurons and decreasing teratoma formation.
001974 (2016) R. Magnard [France] ; Y. Vachez [France] ; C. Carcenac [France] ; P. Krack [France] ; O. David [France] ; M. Savasta [France] ; S. Boulet [France] ; S. Carnicella [France]What can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson's disease?
001F03 (1998) W. Krezel [France] ; N. Ghyselinck ; T A Samad ; V. Dupé ; P. Kastner ; E. Borrelli ; P. ChambonImpaired locomotion and dopamine signaling in retinoid receptor mutant mice.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Receptors, Dopamine D2 (metabolism)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Receptors, Dopamine D2 (metabolism)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Receptors, Dopamine D2 (metabolism)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024